Nearly 2,000 drug plants are overdue for FDA checks after COVID delays, AP finds

Nearly 2,000 drug plants are overdue for FDA checks after COVID delays, AP finds

An Associated Press analysis of FDA records found that government inspectors have not returned to nearly 2,000 factories due for a safety surveillance inspection. (AP Video: Shelby Lum; Mary Conlon; Ajit Solanki. Production: Shelby Lum). Read more: https://bit.ly/4gbCMlQ

#fda #covid19 #news

Subscribe: http://smarturl.it/AssociatedPress
Read more: https://apnews.com​

This video may be available for archive licensing via https://newsroom.ap.org/home

source

Click for the latest news…